Australian Statistics on Medicines 2011

Table 1 - Antineoplastic and Immunomodulating Agents

L01 - ANTINEOPLASTIC AGENTS

2011
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ANTINEOPLASTIC AGENTS
ALKYLATING AGENTS
NITROGEN MUSTARD ANALOGUES
L01AA02 CHLORAMBUCIL
P 1163F Tablet 2mg - - 3,068 372,900
L01AA01 CYCLOPHOSPHAMIDE
P 1031G Injection 2g (solvent required) - - 10,305 595,376
P 1079T Injection 500mg (solvent required) - - 4,971 201,630
P 1080W Injection 1g (solvent required) - - 5,709 192,735
P 1266P Tablet 50mg - - 9,464 283,840
P 5914G Injection 500mg (solvent required) - - 3,419 56,188
P 5915H Injection 1g (solvent required) - - 5,570 118,352
P 5916J Injection 2g (solvent required) - - 2,201 93,473
P 6704W Injection 500 mg 10mL and NS - - 735 32,919
P 6710E Injection 1g 10mL and NS - - 1,483 54,623
P 7055H Injection 2g 10mL and NS - - 1,311 78,212
L01AA06 IFOSFAMIDE
P 5943T Powder for I.V. injection 1g - - 290 52,229
P 5944W Powder for I.V. injection 2g - - 228 78,973
P 8076C Powder for I.V. injection 1g - - 465 168,874
P 8077D Powder for I.V. injection 2g - - 1,042 658,563
L01AA03 MELPHALAN
P 2547C Tablet 2mg - - 3,036 146,900
ALKYL SULPHONATES
L01AB01 BUSULPHAN
P 1128J Tablet 2mg - - 386 33,004
NITROSOUREAS
L01AD05 FOTEMUSTINE
P 5900M Powder for injection 208mg with solvent - - 193 209,276
P 8786K Powder for injection 208mg with solvent - - 619 910,890
OTHER ALKYLATING AGENTS
L01AX03 TEMOZOLOMIDE
P 8378Y Capsule 5mg - - 226 64,760
P 8379B Capsule 20mg 5 - - 1,051 724,208
P 8380C Capsule 100mg 5 - - 4,612 11,289,113
P 8381D Capsule 250mg 5 - - 1,517 2,820,846
P 8819E Capsule 5mg 15 - - 318 126,903
P 8820F Capsule 20mg 15 - - 425 294,492
P 8821G Capsule 100mg 15 - - 658 1,665,408
P 9361Q Capsule 140mg 15 - - 1,103 3,719,077
P 9362R Capsule 140mg 5 - - 1,516 3,978,846
ANTIMETABOLITES
FOLIC ACID ANALOGUES
L01BA01 METHOTREXATE
P 1622J Tablet 2.5mg - - 62,435 814,485
ANTIMETABOLITES
P 1623K Tablet 10mg - - 117,068 5,254,740
P 2272N Tablet 10mg 15 - - 38,236 831,937
P 2395C Injection 50mg in 2mL - - 18,046 641,138
P 2396D Injection 5mg in 2mL - - 1,620 118,413
P 5875F Solution concentrate I.V. infusion 1000mg in 10mL - - 202 19,090
P 5962T Injection 5mg in 2mL - - 793 12,486
P 5963W Injection 50mg in 2mL - - 312 5,320
P 8851W Solution concentrate I.V. infusion 1000mg in 10mL - - 410 93,989
P 8852X Solution concentrate I.V. infusion 5000mg in 50mL - - 249 150,647
P 8863L Solution concentrate I.V. infusion 500mg in 20mL - - 173 14,399
L01BA04 PEMETREXED
P 5834C Powder for I.V. infusion 500mg (base) 2 - - 3,699 5,801,119
P 5835D Powder for I.V. infusion 100mg (base) 1 - - 2,205 1,272,526
P 9130M Powder for I.V. infusion 500mg (base) 2 - - 5,173 9,553,207
P 9131N Powder for I.V. infusion 100mg (base) 1 - - 6,000 11,872,504
L01BA03 RALTITREXED
P 8284B Powder for I.V. infusion 2mg - - 248 209,443
PURINE ANALOGUES
L01BB05 FLUDARABINE
P 5840J Powder for I.V. injection 50mg 5 - - 255 135,186
P 5841K Solution for I.V. injection 50mg in 2mL 5 - - 227 114,624
P 9184J Tablet 10mg 20 - - 807 773,506
P 9185K Powder for I.V. injection 50mg 5 - - 493 644,120
P 9207N Solution for I.V. injection 50mg in 2mL 5 - - 256 320,852
L01BB02 MERCAPTOPURINE
P 1598D Tablet 50mg - - 20,884 5,112,990
L01BB03 THIOGUANINE
P 1233X Tablet 40mg - - 648 172,405
PYRIMIDINE ANALOGUES
L01BC07 AZACITIDINE
P 6100C Powder for injection 100mg - - 379 2,924,159
P 6138C Powder for injection 100mg - - 290 2,193,399
L01BC06 CAPECITABINE
P 8361C Tablet 150mg - - 1,732 240,190
P 8362D Tablet 500mg 120 - - 29,034 20,599,474
L01BC01 CYTARABINE
P 2884T Injection set containing 100mg and 5mL solvent - - 1,516 946,122
P 5918L Injection set containing 100mg and 5mL solvent - - 643 46,978
L01BC02 FLUOROURACIL
P 2528C Injection 500mg in 10mL - - 35,672 1,947,236
P 4222F Cream 50mg per g (5%) 20g - - 101,789 5,685,649
P 5808Q Injection 5000mg in 100mL 1 - - 169 5,863
P 5872C Injection 1000mg in 20mL 5 - - 9,548 248,202
ANTIMETABOLITES
P 5935J Injection 500mg in 10mL - - 11,697 337,206
P 8995K Injection 2500mg in 50mL 2 - - 151 6,719
P 8996L Injection 5000mg in 100mL 1 - - 238 11,656
P 9005Y Injection 1000mg in 20mL 5 - - 12,363 602,946
L01BC05 GEMCITABINE
P 5843M Solution concentrate for I.V. infusion 200mg (base) in 20mL - - 164 16,786
P 5844N Solution concentrate for I.V. infusion 1000mg (base) in 100mL - - 635 141,110
P 5845P Solution concentrate for I.V. infusion 2gm (base) - - 854 280,144
P 5852B Solution concentrate for I.V. infusion 500mg (base) in 50mL 4 - - 290 35,756
P 5936K Powder for I.V. infusion 200mg (base) - - 4,803 463,119
P 5937L Powder for I.V. infusion 1gm (base) - - 7,388 1,636,951
P 8049P Powder for I.V. infusion 200mg (base) - - 4,735 1,611,400
P 8050Q Powder for I.V. infusion 1gm (base) - - 10,584 6,093,187
P 9401T Solution concentrate for I.V. infusion 200mg (base) in 20mL - - 1,056 334,105
P 9402W Solution concentrate for I.V. infusion 1000mg (base) in 100mL - - 1,232 657,100
P 9414L Solution concentrate for I.V. infusion 2gm (base) - - 3,428 2,683,005
P 9463C Solution concentrate for I.V. infusion 500mg (base) in 50mL 4 - - 770 342,068
PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
VINCA ALKALOIDS AND ANALOGUES
L01CA01 VINBLASTINE SULPHATE
P 2199R Injection set containing 10mg and 10mL solvent - - 1,270 173,963
P 5989F Injection set containing 10mg and 10mL solvent - - 1,407 71,519
L01CA02 VINCRISTINE SULPHATE
P 2374Y Injection set containing 1mg and 1mL solvent - - 5,097 585,586
P 5991H Injection set containing 1mg and 1mL solvent - - 4,301 116,439
L01CA04 VINORELBINE
P 5992J Solution for I.V. infusion 10mg (base) in 1mL - - 497 105,778
P 5993K Solution for I.V. infusion 50mg (base) in 5mL - - 1,599 505,211
P 8280T Solution for I.V. infusion 10mg (base) in 1mL - - 812 697,460
P 8281W Solution for I.V. infusion 50mg (base) in 5mL - - 1,799 1,592,442
P 9009E Capsule 20mg (base) 20 - - 135 205,332
PODOPHYLLOTOXIN DERIVATIVES
L01CB01 ETOPOSIDE
P 1389D Capsule 100mg - - 504 178,884
P 1390E Solution for I.V. infusion 100mg in 5mL - - 2,980 470,522
P 1396L Capsule 50mg - - 700 286,551
P 5931E Solution for I.V. infusion 100mg in 5mL - - 801 67,685
P 5932F Powder for I.V. infusion 100mg (as phosphate) - - 4,751 379,865
P 5933G Powder for I.V. infusion 1g (as phosphate) - - 177 48,404
P 8120J Powder for I.V. infusion 100mg (as phosphate) - - 3,237 493,597
P 8515E Powder for I.V. infusion 1g (as phosphate) - - 1,958 617,475
P 9010F Capsule 30mg,16 - - 313 638,713
TAXANES
PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
L01CD02 DOCETAXEL
P 5270J Solution concentrate for I.V. infusion 20mg in 1mL 2 - - 296 440,170
P 5271K Injection set containing 1 single use vial concentrate for I.V. infusion 20mg (anhydrous) 2 - - 370 481,515
P 5272L Solution concentrate for I.V. infusion 80mg in 4mL 1 - - 252 528,738
P 5273M Injection set containing 1 single use vial concentrate for I.V. infusion 80mg (anhydrous) 1 - - 516 1,066,166
P 5274N Solution concentrate for I.V. infusion 140mg in 7mL - - 179 397,324
P 5428Q Solution concentrate for I.V. infusion 20mg in 1mL 1 - - 175 320,397
P 5429R Solution concentrate for I.V. infusion 20mg in 2mL 1 - - 122 200,002
P 5430T Injection set containing 1 single use vial concentrate for I.V. infusion 20mg (anhydrous) 2 - - 241 411,206
P 5431W Solution concentrate for I.V. infusion 80mg in 4mL 1 - - 151 333,820
P 5433Y Injection set containing 1 single use vial concentrate for I.V. infusion 80mg (andydrous) 1 - - 213 478,311
P 5463M Solution concentrate for I.V. infusion 20mg in 1mL 2 - - 2,380 3,464,919
P 5464N Solution concentrate for I.V. infusion 80mg in 4mL - - 3,452 7,308,555
P 5486R Solution concentrate for I.V. infusion 20mg in 2mL 2 - - 771 1,304,260
P 5487T Solution concentrate for I.V. infusion 80mg in 8mL 1 - - 546 1,298,446
P 5595L Injection set containing 1 single use vial concentrate for I.V. infusion 20mg (anhydrous) 2 - - 114 57,081
P 5596M Solution concentrate for I.V. infusion 80mg in 4mL 1 - - 122 169,851
P 5811W Solution concentrate for I.V. infusion 20mg in 1mL 2 - - 227 137,803
P 5812X Injection set containing 1 single use vial concentrate for I.V. infusion 20mg (anhydrous) 2 - - 163 89,946
P 5813Y Solution concentrate for I.V. infusion 80mg in 4mL 1 - - 258 333,925
P 5814B Injection set containing 1 single use vial concentrate for I.V. infusion 80mg (anhydrous) 1 - - 211 309,661
P 5855E Solution concentrate for I.V. infusion 20mg in 1mL 2 - - 360 206,127
P 5856F Solution concentrate for I.V. infusion 80mg in 4mL 1 - - 663 980,977
P 5860K Solution concentrate for I.V. infusion 20mg in 2mL 2 - - 181 88,793
P 5861L Solution concentrate for I.V. infusion 80mg in 8mL 1 - - 301 406,718
P 5862M Solution concentrate for I.V. infusion 160mg in 16mL 1 - - 252 582,347
P 5864P Solution concentrate for I.V. infusion 20mg in 1mL 2 - - 206 107,532
P 5866R Injection set containing 1 single use vial concentrate for I.V. infusion 20mg (anhydrous) 2 - - 270 158,848
P 5867T Solution concentrate for I.V. infusion 80mg in 4mL 1 - - 318 427,517
P 5869X Injection set containing 1 single use vial concentrate for I.V. infusion 80mg (anhydrous) - - 258 332,770
P 5921P Injection set containing I.V. infusion 20mg - - 3,011 1,718,497
P 5922Q Injection set containing I.V. infusion 80mg - - 4,294 5,851,199
P 8071T Injection set containing I.V. infusion 20mg - - 6,524 10,835,714
P 8074Y Injection set containing I.V. infusion 80mg - - 7,415 16,431,278
P 8967Y Solution concentrate for I.V. infusion 160mg in 16mL - - 268 686,621
P 8986Y Solution concentrate for I.V. infusion 20mg in 1mL 2 - - 253 391,632
P 8988C Injection set containing 1 single use vial concentrate for I.V. infusion 20mg (anhydrous) 2 - - 424 667,458
P 8989D Solution concentrate for I.V. infusion 80mg in 4mL - - 278 578,351
P 8991F Injection set containing 1 single use vial concentrate for I.V. infusion 80mg (anhydrous) 1 - - 448 881,602
P 9291B Injection set containing 1 single use vial concentrate for I.V. infusion 20mg (anhydrous) - - 291 447,416
L01CD01 PACLITAXEL
P 3017T Solution for I.V. infusion 150mg in 25mL - - 5,000 6,925,701
P 3026G Solution for I.V. infusion 30mg in 5mL - - 6,231 4,339,159
PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
P 5847R Solution for I.V. infusion 100mg (base) 1 - - 5,287 3,572,771
P 5973J Solution for I.V. infusion 30mg in 5mL - - 2,424 499,172
P 5974K Solution for I.V. infusion 100mg in 16.7mL - - 1,783 776,244
P 5975L Solution for I.V. infusion 150mg in 25mL - - 1,843 1,014,326
P 5976M Solution for I.V. infusion 300mg in 50mL - - 1,685 1,671,398
P 8018B Solution for I.V. infusion 100mg in 16.7mL - - 3,936 4,273,009
P 8360B Solution for I.V. infusion 300mg in 50mL - - 3,647 4,495,121
P 9415M Solution for I.V. infusion 100mg (base) 1 - - 6,464 12,920,905
CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
ANTHRACYCLINES AND RELATED SUBSTANCES
L01DB01 DOXORUBICIN HYDROCHLORIDE
P 1336H Solution for I.V. or intravesical 10mg - - 702 22,382
P 1340M Solution for I.V. or intravesical 20mg - - 532 34,556
P 1342P Solution for I.V. or intravesical 50mg - - 7,919 772,057
P 5879K Solution for I.V. or intravesical 100mg in 50mL - - 2,967 172,501
P 5880L Solution for I.V. or intravesical 200mg in 100mL - - 489 56,856
P 5891C Solution for I.V. infusion 20mg in 10mL - - 746 656,631
P 5892D Suspn for IV infusion 50mg in 25mL - - 701 1,078,359
P 5925W Solution for I.V. or intravesical 10mg - - 532 6,474
P 5926X Solution for I.V. or intravesical 20mg - - 857 23,948
P 5927Y Solution for I.V. or intravesical 50mg - - 3,197 154,885
P 8569B Suspn for IV infusion 20mg in 10mL - - 1,799 3,692,437
P 8570C Suspn for IV infusion 50mg in 25mL - - 1,315 2,828,627
P 8827N Solution for I.V. or intravesical 100mg in 50mL - - 5,550 424,184
P 8828P Solution for I.V. or intravesical 200mg in 100mL - - 638 90,398
L01DB03 EPIRUBICIN HYDROCHLORIDE
P 1375J Solution for I.V. injection 10mg in 5mL 4 - - 424 58,785
P 1376K Solution for I.V. injection 20mg in 10mL 4 - - 189 50,231
P 1377L Solution for I.V. injection 50mg in 25mL 3 - - 4,298 3,184,855
P 5884Q Solution for injection 200mg in 100mL - - 1,256 872,559
P 5885R Solution for injection 100mg in 50mL 2 - - 1,651 799,767
P 5928B Solution for I.V. injection 10mg in 5mL 4 - - 527 35,020
P 5929C Solution for I.V. injection 20mg in 10mL 4 - - 526 62,062
P 5930D Solution for I.V. injection 50mg in 25mL 3 - - 1,394 569,320
P 8817C Solution for injection 100mg in 50mL 2 - - 2,045 1,396,197
P 8858F Solution for injection 200mg in 100mL - - 1,519 1,219,574
L01DB06 IDARUBICIN HYDROCHLORIDE
P 8531B Solution for I.V. injection 10mg in 10mL - - 135 247,595
L01DB07 MITOZANTRONE
P 1929M Injection 20mg in 10mL - - 586 105,481
P 1930N Injection 25mg in 12.5mL - - 495 105,274
P 5965Y Injection 20mg in 10mL - - 136 18,973
OTHER CYTOTOXIC ANTIBIOTICS
CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
L01DC01 BLEOMYCIN
P 2315W Injection 15,000 units (solvent required) - - 1,189 373,523
P 5903Q Injection 15,000 units (solvent required) - - 2,094 180,191
OTHER ANTINEOPLASTIC AGENTS
PLATINUM COMPOUNDS
L01XA02 CARBOPLATIN
P 1160C Solution for I.V. injection 50mg in 5mL - - 1,869 102,413
P 1161D Solution for I.V. injection 150mg in 15mL - - 13,906 4,958,238
P 1162E Solution for I.V. injection 450mg in 45mL - - 8,119 1,871,220
P 5906W Solution for I.V. injection 50mg in 5mL - - 2,634 99,908
P 5907X Solution for I.V. injection 150mg in 15mL - - 6,917 1,005,410
P 5908Y Solution for I.V. injection 450mg in 45mL - - 6,952 974,981
L01XA01 CISPLATIN
P 2578Q I.V. injection 10mg in 10mL - - 216 3,656
P 2579R I.V. injection 50mg in 50mL - - 4,307 144,242
P 2580T I.V. injection 100mg in 100mL - - 10,813 521,828
P 5909B I.V. injection 10mg in 10mL - - 138 782
P 5910C I.V. injection 50mg in 50mL - - 1,962 24,024
P 5911D I.V. injection 100mg in 100mL - - 4,198 138,816
L01XA03 OXALIPLATIN
P 2310N Powder for I.V. infusion 200mg in 40mL - - 3,997 4,976,199
P 5877H Solution for I.V. infusion 50mg in 10mL - - 2,318 547,035
P 5878J Solution for I.V. infusion 100mg in 20mL - - 3,481 1,676,669
P 5994L Powder for I.V. infusion 50mg - - 1,477 415,028
P 5995M Powder for I.V. infusion 100mg - - 2,624 1,824,874
P 5999R Powder for I.V. infusion 200mg in 40mL - - 2,401 1,917,171
P 8539K Powder for I.V. infusion 50mg - - 5,828 4,932,837
P 8540L Powder for I.V. infusion 100mg - - 6,071 7,586,004
P 8847P Solution for I.V. infusion 50mg in 10mL - - 2,924 2,366,717
P 8848Q Solution for I.V. infusion 100mg in 20mL - - 3,013 3,262,456
MONOCLONAL ANTIBODIES
L01XC07 BEVACIZUMAB
P 5849W Soln for IV infusion 100mg/4mL - - 5,330 2,987,618
P 5850X Soln for IV infusion 400mg/16mL - - 6,019 10,916,840
P 9442Y Soln for IV infusion 100mg/4mL - - 10,531 19,089,552
P 9443B Soln for IV infusion 400mg/16mL - - 12,730 33,671,465
L01XC06 CETUXIMAB
P 5447Q Solution for IV infusion 100mg in 20mL 1 - - 878 2,162,802
P 5448R Solution for IV infusion 500mg in 100mL 1 - - 1,357 5,547,879
P 5599Q Solution for IV infusion 100mg in 20mL 1 - - 424 231,198
P 5600R Solution for IV infusion 500mg in 100mL 1 - - 742 1,370,820
P 5836E Solution for IV infusion 100mg in 20mL 1 - - 329 145,607
P 5837F Solution for IV infusion 500mg in 100mL 1 - - 223 395,560
OTHER ANTINEOPLASTIC AGENTS
P 5838G Solution for IV infusion 100mg in 20mL 1 - - 140 73,656
P 5839H Solution for IV infusion 500mg in 100mL 1 - - 367 671,770
P 9136W Solution for IV infusion 100mg in 20mL 1 - - 119 167,225
P 9137X Solution for IV infusion 500mg in 100mL 1 - - 151 363,311
P 9138Y Solution for IV infusion 100mg in 20mL 1 - - 270 459,407
P 9139B Solution for IV infusion 500mg in 100mL 1 - - 391 927,042
L01XC02 RITUXIMAB
P 5896H Solution for IV infusion 100mg\10mL - - 5,803 4,496,375
P 5897J Solution for IV infusion 500mg\50mL - - 4,580 10,455,430
P 5978P Solution for IV infusion 100mg\10mL - - 5,078 4,106,134
P 5979Q Solution for IV infusion 500mg\50mL - - 4,538 10,317,352
P 8293L Solution for IV infusion 100mg\10mL - - 12,908 16,269,769
P 8294M Solution for IV infusion 500mg\50mL - - 13,316 33,726,683
P 8665C Solution for IV infusion 100mg\10mL - - 11,019 14,375,934
P 8666D Solution for IV infusion 500mg\50mL - - 10,752 26,820,525
P 9611W Solution for IV infusion 500mg\50mL - - 738 3,360,435
L01XC03 TRASTUZUMAB
P 6497Y Powder for IV infusion 150mg - - 9,762 33,220,609
P 9691C Powder for IV infusion 60mg - - 3,750 7,950,331
PROTEIN KINASE INHIBITORS
L01XE06 DASATINIB
P 2482P Tablet 50mg 60 - - 483 2,569,222
P 2485T Tablet 70mg 60 - - 227 1,454,307
P 9283N Tablet 50mg 60 - - 183 966,843
P 9341P Tablet 100mg 60 - - 434 2,306,718
P 9342Q Tablet 100mg 60 - - 486 2,559,750
L01XE03 ERLOTINIB
P 9166K Tablet 25mg (as hydrochloride) 30 - - 426 575,934
P 9167L Tablet 100mg (as hydrochloride) 30 - - 1,553 4,224,266
P 9168M Tablet 150mg (as hydrochloride) 30 - - 4,704 15,790,000
L01XE02 GEFITINIB
P 8769M Tablet 250mg 30 - - 383 1,492,942
L01XE01 IMATINIB
P 5444M Tablet 400mg (as mesylate) 30 - - 135 529,574
P 9111M Tablet 100mg (base) 60 - - 718 2,091,988
P 9112N Tablet 400mg (base) 30 - - 2,901 11,516,541
P 9113P Tablet 100mg (base) 60 - - 5,381 20,245,598
P 9114Q Tablet 400mg (base) 30 - - 13,733 57,487,362
P 9115R Tablet 100mg (base) 60 - - 502 2,126,859
P 9116T Tablet 400mg (base) 30 - - 892 4,402,203
P 9123E Tablet 100mg (base) 60 - - 247 725,124
P 9124F Tablet 400mg (base) 30 - - 214 878,778
L01XE07 LAPATINIB
OTHER ANTINEOPLASTIC AGENTS
P 9148L Tablet 250mg 140 - - 1,615 5,444,098
L01XE08 NILOTINIB
P 9171Q Capsule 200mg (as hydrochloride monohydrate) 112 - - 1,031 5,656,562
P 9285Q Capsule 200mg (as hydrochloride monohydrate) 112 - - 608 3,343,816
L01XE05 SORAFENIB
P 9380Q Tablet 200mg (as tosylate) 120 - - 1,377 8,889,156
L01XE04 SUNITINIB
P 9417P Capsule 12.5mg (as malate) 28 - - 170 322,837
P 9418Q Capsule 25mg (as malate) 28 - - 280 1,010,356
P 9419R Capsule 50mg (as malate) 28 - - 542 3,822,448
P 9420T Capsule 12.5mg (as malate) 28 - - 1,332 2,702,163
P 9421W Capsule 25mg (as malate) 28 - - 2,125 7,574,434
P 9422X Capsule 50mg (as malate) 28 - - 1,119 7,796,750
P 9489K Capsule 25mg (as malate) 28 - - 154 548,232
P 9490L Capsule 50mg (as malate) 28 - - 121 842,049
OTHER ANTINEOPLASTIC AGENTS
L01XX27 ARSENIC TRIOXIDE
P 5851Y Injection concentrate 10mg in 10mL 60 - - 113 133,475
L01XX32 BORTEZOMIB
P 5488W Powder for inject 3.5mg (solvent required) 4 - - 186 1,348,180
P 9117W Powder for injection 3.5mg (solvent required) 4 - - 1,961 14,223,459
P 9118X Powder for injection 3.5mg (solvent required) 4 - - 149 1,072,305
L01XX05 HYDROXYUREA
P 3093T Capsule 500mg - - 36,148 2,783,999
L01XX19 IRINOTECAN
P 5833B I V injection 500mg in 25mL - - 796 598,920
P 5846Q I V injection 300mg in 15mL - - 1,376 688,605
P 5958N I V injection 40mg in 2mL - - 1,968 149,229
P 5959P I V injection 100mg in 5mL - - 3,438 1,021,147
P 8414W I V injection 40mg in 2mL - - 2,054 517,565
P 8415X I V injection 100mg in 5mL - - 4,780 3,010,911
P 9119Y I V injection 500mg in 25mL - - 1,751 1,589,124
P 9410G I V injection 300mg in 15mL - - 4,825 2,964,728
L01XX17 TOPOTECAN
P 5985B Powder for I.V. infusion 4mg (base) - - 127 135,036
P 8199M Powder for I.V. infusion 4mg (base) - - 311 629,204

L02 - ENDOCRINE THERAPY

2011
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
ENDOCRINE THERAPY
HORMONES AND RELATED AGENTS
PROGESTOGENS
L02AB02 MEDROXYPROGESTERONE
P 2316X Tablet 200mg 1000.00 MG 1,575 159,597
P 2725K Tablet 100mg 1000.00 MG 1,982 179,175
P 2727M Tablet 250mg 1000.00 MG 169 21,212
P 2728N Tablet 500mg 1000.00 MG 650 81,771
L02AB01 MEGESTROL
P 2734X Tablet 160mg 160.00 MG 1,271 106,074
GONADOTROPHIN RELEASING HORMONE ANALOGUES
L02AE03 GOSERELIN
P 1454M Subcutaneous implant 3.6mg 0.13 MG 20,890 6,939,702
P 8093Y Subcutaneous implant 10.8mg (base) in prefilled injection syringe 0.13 MG 47,349 52,496,206
P 9064C Subcutaneous implant 3.6mg (base) in prefilled injection syringe and 28 tabs 50mg 0.13 MG 381 181,975
P 9065D Subcutaneous implant 10.8mg (base) in prefilled injection syringe and 28 tabs 50mg 0.13 MG 819 1,025,021
P 9066E Subcutaneous implant 10.8mg (base) in prefilled injection syringe and 84 tabs 50mg 0.13 MG 3,455 5,280,311
L02AE02 LEUPRORELIN ACETATE
A 14727 Injection 5mg 0.13 MG 2,684 -
P 8707G Suspn subcutaneous inj (mod rel) 7.5mg inj set 0.13 MG 637 267,649
P 8708H Suspn subcutaneous inj (mod rel) 22.5mg inj set 0.13 MG 4,109 4,554,956
P 8709J Suspn subcutaneous inj (mod rel) 30mg inj set 0.13 MG 1,012 1,468,872
P 8859G Suspn subcutaneous inj (mod rel) 45mg inj set 0.13 MG 3,236 6,890,624
P 8875D I.M. injection (modified release) 7.5mg diluent 0.13 MG 3,457 1,452,363
P 8876E I.M. injection (modified release) 22.5mg diluent 0.13 MG 14,271 15,821,745
P 8877F I.M. injection (modified release) 30mg diluent 0.13 MG 9,171 13,318,173
L02AE04 TRIPTORELIN
P 9379P Powder for I.M. injection (prolonged release) 11.25mg (as embonate) with solvent, syringe and needles 0.13 MG 363 402,478
HORMONE ANTAGONISTS AND RELATED AGENTS
ANTI-ESTROGENS
L02BA01 TAMOXIFEN
P 2109B Tablet 10mg (base) 60 20.00 MG 2,570 95,355
P 2110C Tablet 20mg (base) 60 20.00 MG 123,685 7,108,053
L02BA02 TOREMIFENE
P 8216K Tablet 60mg (base) 60.00 MG 1,550 114,201
ANTI-ANDROGENS
L02BB03 BICALUTAMIDE
P 8094B Tablet 50mg 50.00 MG 39,147 6,268,681
L02BB01 FLUTAMIDE
P 1417N Tablet 250mg 750.00 MG 1,987 399,937
L02BB02 NILUTAMIDE
P 8131Y Tablet 150mg 30.00 MG 4,693 1,124,014
AROMATASE INHIBITORS
L02BG03 ANASTROZOLE
P 8179L Tablet 1mg 1.00 MG 215,668 38,827,728
HORMONE ANTAGONISTS AND RELATED AGENTS
L02BG06 EXEMESTANE
P 8506Q Tablet 25mg 30 25.00 MG 24,287 4,067,637
L02BG04 LETROZOLE
P 8245Y Tablet 2.5mg 2.50 MG 139,035 25,025,780
OTHER HORMONE ANTAGONISTS AND RELATED AGENTS
L02BX02 DEGARELIX
P 5455D Powder for injection 80mg (as acetate) with solvent, syringe and needles 2 1 2.70 MG 707 298,666
P 5456E Powder for injection 120mg (as acetate) with solvent, syringe and needles 2 1 2.70 MG 171 75,439

L03 - IMMUNOSTIMULANTS

2011
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
IMMUNOSTIMULANTS
CYTOKINES AND IMMUNOMODULATORS
COLONY STIMULATING FACTORS
L03AA02 FILGRASTIM
P 6126K Injection 300ug in 1mL 20 0.35 MG 135 211,380
P 6291D Injection 300ug in 0.5mL 20 0.35 MG 2,014 3,726,573
P 6292E Injection 480ug in 0.5mL 20 0.35 MG 812 3,407,194
L03AA13 PEGFILGRASTIM
P 6363X Injection 6mg in 0.6mL single use syringe 0.30 MG 17,242 35,310,849
INTERFERONS
L03AB07 INTERFERON BETA-1a
P 8289G Inj. set 1 vial powder dose 30ug (6,000,000iu) 4.30 UG 1,937 2,046,761
P 8403G Injection 44ug (12,000,000iu) in 0.5mL single syringe 4.30 UG 12,004 12,679,048
P 8805K Injection 30ug (6,000,000iu) in 0.5mL single syringe 4.30 UG 18,843 19,912,194
P 8968B Injection 44ug (12,000,000iu) in 0.5mL syringe dose auto injector 4.30 UG 599 629,949
P 9332E Solution for injection 132ug in 1.5mL multidose cartridge 4 4.30 UG 6,511 7,026,974
L03AB08 INTERFERON BETA-1b
P 8101J Injection set 1 vial powder dose 8,000,000iu 4.00 ME 28,972 34,195,002
L03AB04 INTERFERON-ALFA-2a
P 8180M Solution for injection 3,000,000iu in 0.5mL 15 2.00 ME 1,441 791,336
P 8181N Solution for injection 3,000,000iu in 0.5mL 15 2.00 ME 173 90,955
P 8551C Injection 45,000,000iu in 0.5mL syringe 5 2.00 ME 170 113,228
L03AB05 INTERFERON-ALFA-2b
P 8348J Solution for injection 18,000,000iu in 1.2mL multi-dose pen 3 2.00 ME 227 143,433
L03AB11 PEGINTERFERON ALFA-2a
P 6449K Prefilled syringe 180ug/0.5mL 8 26.00 UG 499 839,165
L03AB61 RIBAVIRIN and PEGINTERFERON ALFA-2a
P 6394M 112 ribavirin 200mg/4 syringes peg-interf alfa-2a 180mcg 2 - - 366 658,626
P 6395N 140 ribavirin 200mg/4 syringes peg-interf alfa-2a 180mcg 2 - - 702 1,438,690
P 6396P 168 ribavirin 200mg/4 syringes peg-interf alfa-2a 180mcg 2 - - 729 1,636,500
L03AB60 RIBAVIRIN and PEGINTERFERON ALFA-2b
P 6405D 112 ribavirin 200mg/4 single use injection pens 2 - - 186 321,435
P 6407F 140 ribavirin 200mg/4 single use injection pens 2 - - 311 565,284
P 6410J 168 ribavirin 200mg/4 single use injection pens 2 - - 120 270,599
OTHER IMMUNOSTIMULANTS
L03AX03 BCG VACCINE
P 1131M Vial powder for intravesical admin. 5x10^8 CFU - - 1,846 1,007,333
P 1140B Injection set 1 vial Powder - - 1,627 561,047
P 5901N Injection set 1 vial Powder - - 1,086 227,070
P 5902P Ampoule containing powder 5x10^8 CFU - - 274 54,920
L03AX13 GLATIRAMER ACETATE
P 8726G Inj 20mg in 1mL single dose prefilled syringe 20.00 MG 26,389 28,830,836

L04 - IMMUNOSUPPRESSANTS

2011
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
IMMUNOSUPPRESSANTS
IMMUNOSUPPRESSANTS
SELECTIVE IMMUNOSUPPRESSANTS
L04AA24 ABATACEPT
P 9621J Powder for I.V. infusion 250mg 27.00 MG 4,187 6,761,459
L04AA18 EVEROLIMUS
P 8840G Tablet 0.25mg 60 1.50 MG 200 61,174
P 8841H Tablet 0.5mg 60 1.50 MG 767 556,187
P 8842J Tablet 0.75mg 120 1.50 MG 420 647,017
P 9352F Tablet 1mg 120 1.50 MG 129 283,404
L04AA27 FINGOLIMOD
P 5262Y Capsule 500ug (as hydrochloride) 28 0.50 MG 5,189 12,013,373
L04AA13 LEFLUNOMIDE
P 5449T Tablet 10mg 30 20.00 MG 4,347 334,388
P 5450W Tablet 20mg 30 20.00 MG 8,257 938,025
P 8374R Tablet 10mg 30 20.00 MG 52,418 4,488,435
P 8375T Tablet 20mg 30 20.00 MG 117,464 14,856,128
L04AA06 MYCOPHENOLIC ACID
P 6208R Capsule 250mg 600 2.00 GM 277 113,944
P 6209T Tablet 500mg 300 2.00 GM 1,238 960,706
P 6370G Tablet (enteric coated) 360mg 240 2.00 GM 246 168,452
P 8649F Capsule 250mg 300 2.00 GM 1,495 888,473
P 8650G Capsule 500mg 150 2.00 GM 10,106 6,512,489
P 8652J Tablet (enteric coated) 180mg 120 2.00 GM 364 103,515
P 8653K Tablet (enteric coated) 360mg 120 2.00 GM 1,832 934,495
L04AA23 NATALIZUMAB
P 9624M Sol.concentrate for I.V. infusion 300mg in 15mL 10.00 MG 4,756 9,967,651
L04AA10 SIROLIMUS
P 8724E Tablet 1mg 100 3.00 MG 449 383,651
P 8833X Tablet 2mg 100 3.00 MG 199 324,800
TUMOR NECROSIS FACTOR ALPHA INHIBITORS
L04AB04 ADALIMUMAB
P 8737W Injection 40mg in 0.8mL prefilled syringe 2.90 MG 1,323 2,344,912
P 8741C Injection 40mg in 0.8mL prefilled syringe 2.90 MG 12,063 21,386,484
P 8963R Injection 40mg in 0.8mL prefilled syringe 2 2.90 MG 119 211,400
P 8964T Injection 40mg in 0.8mL prefilled syringe 2 2.90 MG 119 210,847
P 8965W Injection 40mg in 0.8mL prefilled pen 2 2.90 MG 250 442,106
P 8966X Injection 40mg in 0.8mL prefilled pen 2 2.90 MG 368 651,801
P 9033K Injection 40mg in 0.8mL prefilled syringe 2.90 MG 351 622,874
P 9034L Injection 40mg in 0.8mL prefilled syringe 2.90 MG 2,697 4,785,378
P 9077R Injection 40mg in 0.8mL prefilled syringe 2 2.90 MG 332 589,088
P 9078T Injection 40mg in 0.8mL prefilled syringe 2 2.90 MG 2,901 5,141,488
P 9099X Injection 40mg in 0.8mL prefilled syringe 2.90 MG 4,799 8,516,055
P 9100Y Injection 40mg in 0.8mL prefilled syringe 2 2.90 MG 30,176 53,528,847
P 9101B Injection 40mg in 0.8mL prefilled syringe 2 2.90 MG 1,522 2,697,221
IMMUNOSUPPRESSANTS
P 9102C Injection 40mg in 0.8mL prefilled syringe 2 2.90 MG 9,370 16,624,137
P 9103D Injection 40mg in 0.8mL prefilled syringe 2 2.90 MG 1,763 3,129,872
P 9104E Injection 40mg in 0.8mL prefilled syringe 2 2.90 MG 10,140 17,990,941
P 9186L Injection 40mg in 0.8mL prefilled syringe 6 2.90 MG 203 1,033,332
P 9187M Injection 40mg in 0.8mL prefilled pen 6 2.90 MG 557 2,833,101
P 9188N Injection 40mg in 0.8mL prefilled syringe 2 2.90 MG 539 954,746
P 9189P Injection 40mg in 0.8mL prefilled syringe 2 2.90 MG 4,019 7,133,256
P 9190Q Injection 40mg in 0.8mL prefilled pen 2 2.90 MG 1,679 2,980,579
P 9191R Injection 40mg in 0.8mL prefilled pen 2 2.90 MG 11,212 19,900,161
P 9425C Injection 40mg in 0.8mL prefilled syringe 2 2.90 MG 728 1,291,356
P 9426D Injection 40mg in 0.8mL prefilled pen 2 2.90 MG 875 1,552,187
P 9427E Injection 40mg in 0.8mL prefilled syringe 2 2.90 MG 3,634 6,443,237
P 9428F Injection 40mg in 0.8mL prefilled pen 2 2.90 MG 4,439 7,871,173
P 9680L Injection 40mg in 0.8mL prefilled pen 2 2.90 MG 127 212,905
L04AB05 CERTOLIZUMAB PEGOL
P 3425G Injection 200mg in 1mL single use prefilled syringe 1 14.00 MG 4,286 7,320,227
L04AB01 ETANERCEPT
P 3449M Injection 50mg in 1 mL single use prefilled syringes 4 1 7.00 MG 240 425,849
P 6367D Injection set 4 vial pdr 25mg and 4 syringe solvent 7.00 MG 469 793,614
P 8637N Injection set 4 vial pdr 25mg and 4 syringe solvent 7.00 MG 112 204,848
P 8638P Injection set 4 vial pdr 25mg and 4 syringe solvent 7.00 MG 2,547 4,697,721
P 8779C Injection set 4 vial pdr 25mg and 4 syringe solvent 7.00 MG 743 1,348,012
P 9036N Injection set 4 vial pdr 25mg and 4 syringe solvent 7.00 MG 345 637,320
P 9085E Injection 50mg in 1mL single use prefilled syr, 4 7.00 MG 375 666,395
P 9086F Injection 50mg in 1mL single use prefilled syr, 4 7.00 MG 4,839 8,586,405
P 9087G Injection 50mg in 1mL single use prefilled syr, 4 7.00 MG 276 489,763
P 9088H Injection 50mg in 1mL single use prefilled syr, 4 7.00 MG 3,083 5,470,293
P 9089J Injection 50mg in 1mL single use prefilled syr, 4 7.00 MG 1,080 1,916,576
P 9090K Injection 50mg in 1mL single use prefilled syr, 4 7.00 MG 19,164 34,020,613
P 9091L Injection 50mg in 1mL single use prefilled syr, 4 7.00 MG 123 218,394
P 9431J Injection 50mg in 1mL single use prefilled syr, 4 7.00 MG 2,364 4,195,387
P 9455P Injection 50mg in 1mL single use auto injector, 4 7.00 MG 922 1,636,115
P 9456Q Injection 50mg in 1mL single use auto injector, 4 7.00 MG 5,097 9,044,217
P 9457R Injection 50mg in 1mL single use auto injector, 4 7.00 MG 901 1,609,315
P 9458T Injection 50mg in 1mL single use auto injector, 4 7.00 MG 4,133 7,338,944
P 9459W Injection 50mg in 1mL single use auto injector, 4 7.00 MG 3,669 6,522,988
P 9460X Injection 50mg in 1mL single use auto injector, 4 7.00 MG 19,266 34,216,717
P 9461Y Injection 50mg in 1mL single use auto injector, 4 7.00 MG 286 507,580
P 9462B Injection 50mg in 1mL single use auto injector, 4 7.00 MG 1,311 2,326,309
L04AB06 GOLIMUMAB
P 3426H Injection 50mg in 0.5mL single use prefilled syringe 1 1.66 MG 1,933 3,439,093
P 3427J Injection 50mg in 0.5mL single use prefilled pen 1 1.66 MG 814 1,446,714
P 3428K Injection 50mg in 0.5mL single use prefilled syringe 1 1.66 MG 4,999 8,886,932
IMMUNOSUPPRESSANTS
P 3429L Injection 50mg in 0.5mL single use prefilled pen 1 1.66 MG 1,094 1,944,975
P 3430M Injection 50mg in 0.5mL single use prefilled syringe 1 1.66 MG 811 1,441,488
P 3431N Injection 50mg in 0.5mL single use prefilled pen 1 1.66 MG 338 600,724
P 3432P Injection 50mg in 0.5mL single use prefilled syringe 1 1.66 MG 1,884 3,348,316
P 3433Q Injection 50mg in 0.5mL single use prefilled pen 1 1.66 MG 395 702,004
P 3434R Injection 50mg in 0.5mL single use prefilled syringe 1 1.66 MG 857 1,523,376
P 3435T Injection 50mg in 0.5mL single use prefilled pen 1 1.66 MG 337 598,984
P 3436W Injection 50mg in 0.5mL single use prefilled syringe 1 1.66 MG 2,235 3,972,129
P 3437X Injection 50mg in 0.5mL single use prefilled pen 1 1.66 MG 662 1,176,644
L04AB02 INFLIXIMAB
P 6397Q Powder for I.V. infusion 100mg 1 3.75 MG 762 1,815,776
P 6448J Powder for I.V. infusion 100mg 1 3.75 MG 1,700 5,963,451
P 6496X Powder for I.V. infusion 100mg 1 3.75 MG 469 1,738,274
P 9612X Powder for I.V. infusion 100mg 1 3.75 MG 146 365,897
P 9613Y Powder for I.V. infusion 100mg 1 3.75 MG 2,145 6,830,885
P 9617E Powder for I.V. infusion 100mg 1 3.75 MG 237 907,593
P 9674E Powder for I.V. infusion 100mg 1 3.75 MG 409 1,309,432
INTERLEUKIN INHIBITORS
L04AC07 TOCILIZUMAB
P 9671B Concentrate for injection 80mg in 4mL 1 20.00 MG 4,177 1,842,260
P 9672C Concentrate for injection 200mg in 10mL 1 20.00 MG 1,907 1,089,461
P 9673D Concentrate for injection 400mg in 20mL 1 20.00 MG 5,785 6,953,210
L04AC05 USTEKINUMAB
P 9304Q Injection 45mg in 0.5mL 0.54 MG 1,177 7,168,538
P 9305R Injection 45mg in 0.5mL 0.54 MG 1,677 10,973,299
CALCINEURIN INHIBITORS
L04AD01 CYCLOSPORIN
P 6232B Capsule 10mg (with microemulsion pre-concentrate) 120 0.25 GM 300 24,462
P 6352H Capsule 25mg 120 0.25 GM 1,316 225,401
P 6353J Capsule 50mg 120 0.25 GM 1,129 341,608
P 6354K Capsule 100mg 120 0.25 GM 1,479 790,970
P 8657P Capsule 10mg 120 0.25 GM 1,375 157,800
P 8658Q Capsule 25mg 60 0.25 GM 8,495 1,133,815
P 8659R Capsule 50mg 60 0.25 GM 12,520 2,712,630
P 8660T Capsule 100mg 60 0.25 GM 11,810 4,946,983
P 8661W Oral liquid 100mg per mL 0.25 GM 277 172,128
L04AD02 TACROLIMUS
P 5299X Capsule 0.5mg 30 5.00 MG 279 22,491
P 5300Y Capsule 1mg (once daily prolonged release) 60 5.00 MG 598 192,468
P 5451X Capsule 5mg (once daily prolonged release) 30 5.00 MG 181 131,977
P 6216E Capsule 1mg 200 5.00 MG 849 612,132
P 6328C Capsule 500ug 200 5.00 MG 208 48,202
P 8646C Capsule 500ug 100 5.00 MG 3,956 795,524
IMMUNOSUPPRESSANTS
P 8647D Capsule 1mg 100 5.00 MG 11,221 6,242,627
P 8648E Capsule 5mg 100 5.00 MG 528 754,499
OTHER IMMUNOSUPPRESSANTS
L04AX01 AZATHIOPRINE
P 2687K Tablet 50mg 0.15 GM 148,416 8,179,191
P 2688L Tablet 25mg 0.15 GM 17,053 604,414
L04AX04 LENALIDOMIDE
P 9643M Capsule 10mg 21 10.00 MG 494 2,907,307
P 9644N Capsule 15mg 21 10.00 MG 586 3,883,781
P 9645P Capsule 25mg 21 10.00 MG 1,234 8,613,410
L04AX02 THALIDOMIDE
P 6469L Capsules 50mg 112 0.10 GM 2,820 3,103,418
P 9684Q Capsules 100mg 56 0.10 GM 1,129 1,571,458
Last updated
1 January 2011